Semi-Annual Statement Of Income And Retained Earnings

JCR Pharmaceuticals Co.,Ltd. - Filing #7251173

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-6,650,000,000 JPY
-6,900,000,000 JPY
7,531,000,000 JPY
7,549,000,000 JPY
Non-operating income
Non-operating income
260,000,000 JPY
233,000,000 JPY
1,056,000,000 JPY
1,008,000,000 JPY
Non-operating expenses
Non-operating expenses
1,088,000,000 JPY
902,000,000 JPY
1,324,000,000 JPY
508,000,000 JPY
Ordinary profit (loss)
-7,477,000,000 JPY
-7,569,000,000 JPY
7,264,000,000 JPY
8,048,000,000 JPY
Extraordinary income
Extraordinary income
1,065,000,000 JPY
1,043,000,000 JPY
0 JPY
0 JPY
Extraordinary losses
Extraordinary losses
2,000,000 JPY
2,000,000 JPY
20,000,000 JPY
20,000,000 JPY
Profit (loss) before income taxes
-6,414,000,000 JPY
-6,528,000,000 JPY
7,244,000,000 JPY
8,028,000,000 JPY
Income taxes - current
52,000,000 JPY
-11,000,000 JPY
1,788,000,000 JPY
1,743,000,000 JPY
Income taxes - deferred
-1,771,000,000 JPY
-1,771,000,000 JPY
-80,000,000 JPY
-80,000,000 JPY
Profit (loss)
-4,695,000,000 JPY
-4,746,000,000 JPY
-4,746,000,000 JPY
-4,746,000,000 JPY
-4,746,000,000 JPY
6,364,000,000 JPY
5,536,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY
6,364,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.